Stemcell 73552 WHI-P154
Product Overview
WHI-P154 is an inhibitor of Janus kinase 3 (JAK3) with IC₅₀ values of 28 and 128 μM against human and mouse proteins, respectively (Sudbeck et al.). It has also been reported to show significant inhibition of other kinases, including epidermal growth factor receptor (EGFR) in the nanomolar range (Changelian et al.; Uckun et al.). No significant inhibition of JAK1 or JAK2 has been observed (Sudbeck et al.).
DIFFERENTIATION
· Promotes differentiation of mouse neuronal precursor cells to neurons and oligodendrocytes, but blocks astrocyte differentiation (Kim et al.).
· Abolishes PDGF-induced increases in neurite outgrowth from human neural progenitor cells (Richards et al.).
IMMUNOLOGY
· Inhibits lipopolysaccharide (LPS)-induced nitric oxide synthase expression and nitric oxide production in macrophages and human epithelial cells (Sareila et al.).
CANCER RESEARCH
· Induces apoptosis and cell death in human glioblastoma cell lines U373 and U87. When coupled to EGF, inhibits tumor growth in mouse xenograft models (Narla et al.).
CAS Number:211555-04-3
Alternative Names:JAK3 Inhibitor II, Janus-Associated Kinase 3 Inhibitor II
Chemical Formula:C₁₆H₁₄BrN₃O₃
Molecular Weight:376.2 g/mol
Purity:≥ 98%
Pathway:JAK/STAT
Target:JAK3
Related products
Description | Catalog # | Format |
WHI-P154, 10 mg | 73552 | 10 mg |
WHI-P131 , 10 mg | 73544 | 10 mg |
WHI-P131 , 1 mg | 73542 | 1 mg |
Waste Bags, Liquid Handler, 100 pack | 23103 | 1 EA |
Warranty Re-Instatement Fee | 20208 | 1 EA |
Vitronectin XF Kit | 07190 | 1 Kit |
Vitronectin XF | 07180 | 250 µg/mL |
Ventral Mesencephalon Neurospheres,1vial | 00332 | 1 vial |
Vandetanib, 100 mg | 73534 | 100 mg |
Vandetanib, 10 mg | 73532 | 10 mg |
Valproic Acid (Na Salt), 500 mg | 72292 | 500 mg |
Uante,您的科研物资战略合作伙伴!
重庆市寰宇安泰生物科技有限公司